| Watchdog may ask police to look into Peter Hain’s donations of £100 ...
The watchdog now faces a stark choice between letting him off without punishment or recommending a criminal prosecution if it finds that he broke rules on when donations should be reported. The scale of the donations, as well as Mr Hain’s claim that he was too busy to ensure that the rules were followed properly, have increased significantly the likelihood that it will seek to make an example of him. .
Merck/Schering-Plough Pharmaceuticals Provides Results of the ENHANCE Trial
WHITEHOUSE STATION, N.J. & KENILWORTH, N.J.--(BUSINESS WIRE)--Merck/Schering-Plough Pharmaceuticals announced today the primary endpoint and other results of the ENHANCE (Effect of Combination Ezetimibe and High-Dose Simvastatin vs. Simvastatin Alone on the Atherosclerotic Process in Patients with Heterozygous Familial Hypercholesterolemia) trial. Merck/Schering-Plough has submitted an abstract on the ENHANCE trial for presentation at the American College of Cardiology meeting, which will be held in March 2008, and is awaiting notification of acceptance from the College. .
Save your life, have a health check
READING about preventing catastrophic illness is as unpleasant as reading the fine print on a will, power of attorney or a life insurance policy. Facing our mortality and learning about preventing heart, lung or kidney failure, strokes, amputations, dementia and hip replacements, is not easy, but we should do it as a necessary part of protecting those we love. As medical technologies keep our ageing population alive longer, the over-50s age group will become a heavy burden on the young. The escalating costs of healthcare and private health insurance; the increasing strain on accident and emergency departments, hospitals and nursing homes and the worsening medical and nursing shortage have been identified by the new federal Labor Government as a first-order economic challenge.
|
